Showing results (221-230 of 230) with videos related to
Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 230 results.
European Urology Oncology|October 16, 2021
Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic TestingHong Truong, Rania Sheikh, Ritesh Kotecha, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2016
A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune ProfilingHeather L McArthur, Adi Diab, David B Page, et al.The Oncologist|March 12, 2022
Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal CancerJin K Kim, Michael R Marco, Campbell S D Roxburgh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancerHeather L McArthur, Hope Rugo, Benjamin Nulsen, et al.JAMA Oncology|July 7, 2018
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell CarcinomaMaria I Carlo, Semanti Mukherjee, Diana Mandelker, et al.Nature Cancer|September 1, 2020
Alterations in <i>PTEN</i> and <i>ESR1</i> promote clinical resistance to alpelisib plus aromatase inhibitorsPedram Razavi, Maura N Dickler, Payal D Shah, et al.Nature Communications|January 18, 2020
The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunctionMaria Carmen Inda, Suhasini Joshi, Tai Wang, et al.Nature|October 6, 2016
The epichaperome is an integrated chaperome network that facilitates tumour survivalAnna Rodina, Tai Wang, Pengrong Yan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2022
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant TherapyJulio Garcia-Aguilar, Sujata Patil, Marc J Gollub, et al.Nature Medicine|October 9, 2019
A rectal cancer organoid platform to study individual responses to chemoradiationKaruna Ganesh, Chao Wu, Kevin P O'Rourke, et al.Pageof 23